Synthesis of tritium-labeled (R,R)-4-methoxyfenoterol

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 53, Issue 2, 2010, Pages 68-72

  Kozocas, Joseph A ^a   Bupp, James E ^a   Tanga, Mary J ^a   Pluhar, Joseph T ^b   Wainer, Irving W ^c  

^a SRI INTERNATIONAL   (United States)

^b Moravek Biochemicals Inc ^*  (United States)

^c National Institute on Aging Intramural Research Program   (United States)

Author keywords

Fenoterol; Methoxyfenoterol; Tritium exchange; Tritium labeling

Indexed keywords

FENOTEROL; LABELINGS; METHOXYFENOTEROL; SPECIFIC ACTIVITY; TRITIUM EXCHANGE; TRITIUM LABELING;

TRITIUM;

2',4',6', TRIBROMO 4 METHOXYFENOTEROL; 2',4',6',4 METHOXYFENOTEROL H 3; 4 METHOXYFENOTEROL HYDROCHLORIDE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; RADIOPHARMACEUTICAL AGENT; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BROMINATION; CATALYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; HALOGENATION; HYDROGENATION; ISOTOPE LABELING; RADIOACTIVITY; RADIOCHEMISTRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEREOCHEMISTRY;

EID: 77249090762     PISSN: 03624803     EISSN: 10991344     Source Type: Journal    
DOI: 10.1002/jlcr.1703     Document Type: Article

References (3)

1. K. Jozwiak, C. Khalid, M. J. Tanga, I. Berzetei-Gurske, L. Jimenez, J. A. Kozocas, A. Woo, W. Zhu, R.-P. Xiao, D. R. Abernethy, I. W. Wainer, J. Med. Chem. 2007, 50, 2903-2915.
2. A. Y.-H. Woo, T.-B. Wang, X. Zeng, W. Zhu, D. R. Abernethy, I. W. Wainer, R.-P. Xiao, Mol. Pharmacol. 2009, 75, 158-165.
3. R. H. Mitchell, Y.-H. Lai, R. V. Williams, J. Org. Chem. 1979, 44, 4733-4735.